Newstral
Article
Mmarketwatch.com on 2016-04-05 13:28
Pfizer reports positive results from late-stage trial of psoriatic arthritis drug
Related news
- MAllergan, Paratek Pharma report positive results in late-stage trial of acne treatmentmarketwatch.com
- Psoriatic arthritissouthplattesentinel.com
- MPfizer shares rise on late-stage results for cardiomyopathy therapymarketwatch.com
- MPfizer, BioNTech's COVID vaccine candidate enters late-stage trialmarketwatch.com
- Psoriatic arthritis and yousouthplattesentinel.com
- MAcorda stock surges 10% on positive late-stage Parkinson's resultsmarketwatch.com
- HPsoriatic arthritis treatment advanceshealthguides.healthgrades.com
- MPacira Pharmaceuticals stock rises 2% on positive late-stage trial for opioid-reducing pain medicationmarketwatch.com
- MKeryx stock up 21% after positive late-stage results for anemia drugmarketwatch.com
- HExpert tips for psoriatic arthritishealthguides.healthgrades.com
- HPsoriatic arthritis treatment for youhealthguides.healthgrades.com
- TPsoriasis can precede psoriatic arthritisthemountaineagle.com
- EPsoriatic Arthritis Of The Spineenquirerdemocrat.com
- MPfizer shares rise 1.4% after news of positive late-stage cancer trialmarketwatch.com
- Pfizer begins late-stage testing of Spark's hemophilia B gene therapybizjournals.com
- Pfizer enters late-stage study for oral COVID-19 antiviral drugKVUE News
- MFoamix stock surges 30% on positive late-stage results for acne medicationmarketwatch.com
- MNovocure Ltd. stock surges nearly 50% after positive late-stage trial results in brain cancermarketwatch.com
- MIncyte rerpots positive results in late-stage trial of treatment for GVHDmarketwatch.com